Introduction of Melanotan I Nov 24, 2021 Melanotan IAfamelanotide is a first-in-class, synthetic, 13-amino acid peptide analogue of the endogenous alpha melanocyte-stimulating hormone (-MSH)
Recent GLP-1 Weight Loss Drug Market Developments: Novo Nordisk, Eli Lilly, Amgen, and FDA Lead 20252026 April 2026: Eli Lilly submitted the orforglipron New Drug Application to the FDA for obesity treatment, reporting 14.7% body weight reduction in the ATTAIN-WEIGHT1 Phase 3 trial at the 45mg dose the first oral small molecule GLP-1 receptor agonist NDA submission for dedicated obesity pharmacological treatment in the United States
Collectively, these findings indicate that specific pathogenic members of the gut microbiotaincluding bacteria and fungiactively drive UC pathogenesis through direct and immune-mediated mechanisms
Hundreds of websites are selling fake Ozempic, says company
And the company's stated clinical support model, which the website describes as including access to healthcare professionals, addresses one of the most common concerns about telehealth weight management: feeling unsupported between check-ins
Who Might Be Prescribed B12 (Cyanocobalamin or Methylcobalamin)/Salcaprozate Sodium
